Ines Guessoum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ines Guessoum has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Carole Rémond
Pitié Salpêtrière Hospital Paris France
1 shared publication - Géraldine Lescaille
Department of Oral Surgery, School of Dentistry Université Paris Cité Paris France
1 shared publication - Juliette Rochefort
Université Paris Cité, Paris, France; CIMI Paris, INSERM U1135, Paris, France; Hôpital Universitaire Pitié-Salpêtrière - APHP - Service de médecine bucco dentaire, Paris, France
1 shared publication - Marjorie Zanini
Université Paris Cité UFR d'Odontologie Paris France
1 shared publication - Samantha Elbhar
Pitié Salpêtrière Hospital Paris France
1 shared publication Vanessa Baaroun
Department of Oral Surgery, School of Dentistry Université Paris Cité Paris France
1 shared publication
Latest Publications
- Open Access
- 27 June 2025
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 11 (4) , e70168
Endodontic Consequences of Early Stage of Medication‐Related Osteonecrosis of the Jaw: A Case Report
Objectives: Osteonecrosis of the jaws (MRONJ) is a frequent side effect of antiresorptive (AR) drugs used in oncology. MRONJ may have endodontic consequences, as reported in this clinical case. Material and Methods: A 64‐year‐old woman being treated with antiresorptive (AR) drugs targeting bone metastasis of a primitive breast cancer consulted at the dental service of Pitié‐Salpêtrière Hospital. She first experienced symptomatic apical periodontitis followed by symptomatic irreversible pulpitis, which were initially explained as resulting from occlusal trauma. Despite endodontic treatment, exacerbation of the symptomatology was noted. MRONJ was suspected, and the affected tooth was extracted. Results: The presence of necrotic bone during the surgery confirmed the diagnosis. Surgical treatment led to complete healing and total disappearance of clinical and radiological signs at 4 months. Conclusions: MRONJ can induce alterations in adjacent tooth vascularization and secondary pulpal disease. Early diagnosis is difficult because early‐stage MRONJ occurs without clear radiographic signs.
- 27 June 2025
- Published by Wiley in Clinical and Experimental Dental Research
- Vol. 11 (4) , e70168
Open AccessEndodontic Consequences of Early Stage of Medication‐Related Osteonecrosis of the Jaw: A Case Report
Objectives: Osteonecrosis of the jaws (MRONJ) is a frequent side effect of antiresorptive (AR) drugs used in oncology. MRONJ may have endodontic consequences, as reported in this clinical case. Material and Methods: A 64‐year‐old woman being treated with antiresorptive (AR) drugs targeting bone metastasis of a primitive breast cancer consulted at the dental service of Pitié‐Salpêtrière Hospital. She first experienced symptomatic apical periodontitis followed by symptomatic irreversible pulpitis, which were initially explained as resulting from occlusal trauma. Despite endodontic treatment, exacerbation of the symptomatology was noted. MRONJ was suspected, and the affected tooth was extracted. Results: The presence of necrotic bone during the surgery confirmed the diagnosis. Surgical treatment led to complete healing and total disappearance of clinical and radiological signs at 4 months. Conclusions: MRONJ can induce alterations in adjacent tooth vascularization and secondary pulpal disease. Early diagnosis is difficult because early‐stage MRONJ occurs without clear radiographic signs.